| Literature DB >> 35889462 |
Huabao Chen1, Yingchun Zhao1, Guangwei Qin1, Yan Bi1, Guizhou Yue2, Min Zhang1, Xiaoli Chang1, Xiaoyan Qiu1, Liya Luo1, Chunping Yang1.
Abstract
The separation of chemical components from wild plants to develop new pesticides is a hot topic in current research. To evaluate the antimicrobial effects of metabolites of Ligusticum chuanxiong (CX), we systematically studied the antimicrobial activity of extracts of CX, and the active compounds were isolated, purified and structurally identified. The results of toxicity measurement showed that the extracts of CX had good biological activities against Botrytis cinerea, Sclerotinia sclerotiorum, Alternaria alternata and Pythium aphanidermatum, and the value of EC50 were 130.95, 242.36, 332.73 and 307.29 mg/L, respectively. The results of in vivo determination showed that under the concentration of 1000 mg/L, the control effect of CX extract on Blumeria graminis was more than 40%, and the control effect on Botrytis cinerea was 100%. The antifungal active components of CX were identified as Senkyunolide A and Ligustilide by mass spectrometry and nuclear magnetic resonance. The MIC (minimum inhibitory concentration) value of Senkyunolide A and Ligustilide against Fusarium graminearum were 7.81 and 62.25 mg/L, respectively. As a new botanical fungicide with a brightly exploitative prospect, CX extract has potential research value in the prevention and control of plant diseases.Entities:
Keywords: Ligusticum chuanxiong; Ligustilide; Senkyunolide A; antifungal activity
Mesh:
Substances:
Year: 2022 PMID: 35889462 PMCID: PMC9320862 DOI: 10.3390/molecules27144589
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Toxicity test results of CX plant extracts against 10 kinds of plant pathogens.
| Plant Pathogen | Toxicity Regression | Correlation | EC50 (mg/L) | Confidence Interval (mg/L) |
|---|---|---|---|---|
|
| y = 1.1737x + 5.0210 | 0.9800 | 959.64 | (670,1370) |
|
| y = 4.0417x + 8.5684 | 0.9909 | 130.95 | (110,160) |
|
| y = 0.8628x + 5.1074 | 0.8606 | 750.78 | (310,1810) |
|
| y = 2.8467x + 6.7523 | 0.9536 | 242.36 | (210,280) |
|
| y = 1.2462x + 5.1013 | 0.9804 | 826.49 | (570,1210) |
|
| y = 0.8047x + 5.2308 | 0.9180 | 516.55 | (310,850) |
|
| y = 2.1608x + 6.0327 | 0.9624 | 332.73 | (270,420) |
|
| y = 0.8966x + 5.4595 | 0.9471 | 307.29 | (130,720) |
|
| y = 1.5346x + 5.5024 | 0.9385 | 470.53 | (300,750) |
|
| y = 1.1329x + 5.3577 | 0.9810 | 534.05 | (370,770) |
Control effect of CX extract on Blumeria graminis by pot trial.
| Treatment | Concentration | Protective Activity | Curative Activity | ||||
|---|---|---|---|---|---|---|---|
| (mg/L) | 7 d (%) | 9 d (%) | 11 d (%) | 7 d (%) | 9 d (%) | 11 d (%) | |
| Extracts of CX | 4000 | 68.45 b | 64.71 b | 53.37 b | 55.77 b | 42.31 b | 36.64 b |
| 2000 | 66.71 b | 62.97 b | 51.42 b | 22.00 c | 21.37 c | 15.52 c | |
| 1000 | 52.46 c | 50.50 c | 49.15 b | 19.85 cd | 15.38 d | 11.62 d | |
| 500 | 48.39 cd | 47.37 cd | 48.54 b | 15.79 de | 12.55 e | 4.31 e | |
| 250 | 46.10 d | 43.86 d | 42.34 c | 14.98 e | 10.46 e | 1.71 ef | |
| Prothioconazole | 100 | 92.31 a | 84.53 a | 80.32 a | 88.62 a | 76.35 a | 70.46 a |
Statistical significance was determined using one-way ANOVA. Different lowercase letters in the footnote in the same column show significant difference in the relative disease control efficiency of different treatment at each time points (p < 0.05).
Control effect of CX extract on Fusarium graminearum by pot trial.
| Treatment | Concentration | Protective Effect | Curative Effect | ||||
|---|---|---|---|---|---|---|---|
| (mg/L) | 7 d (%) | 9 d (%) | 11 d (%) | 7 d (%) | 9 d (%) | 11 d (%) | |
| CX | 1000 | 31.26 c | 9.12 c | 7.14 c | 25.01 c | 3.96 c | 2.38 c |
| 4000 | 50.01 b | 39.98 b | 11.90 b | 36.39 b | 32.82 b | 7.14 b | |
| Tebuconazole | 86 | 71.88 a | 81.99 a | 88.10 a | 54.56 a | 87.50 a | 80.95 a |
Statistical significance was determined using one-way ANOVA. Different lowercase letters in the footnote in the same column show significant difference in the relative disease control efficiency of different treatment at each time points (p < 0.05).
In vivo control effect of CX plant extracts on Botrytis cinerea.
| Treatment | Concentration | Protective Effect | Curative Effect | ||||
|---|---|---|---|---|---|---|---|
| (mg/L) | 3 d (%) | 5 d (%) | 7 d (%) | 3 d (%) | 5 d (%) | 7 d (%) | |
| 2000 | 100.00 a | 100.00 a | 100.00 a | 100.00 a | 100.00 a | 100.00 a | |
| CX | 1000 | 100.00 a | 100.00 a | 100.00 a | 100.00 a | 75.00 b | 45.47 b |
| 500 | 100.00 a | 62.51 b | 55.56 b | 100.00 a | 57.13 c | 9.11 c | |
| Pyraclostrobin | 100 | 100.00 a | 100.00 a | 100.00 a | 100.00 a | 100.00 a | 100.00 a |
Statistical significance was determined using one-way ANOVA. Different lowercase letters in the footnote in the same column show significant difference in the relative disease control efficiency of different treatment at each time points (p < 0.05).
In vivo control effect of CX plant extracts on Colletotrichum gloeosporioides.
| Treatment | Protective Effect | Curative Al Effect | |||
|---|---|---|---|---|---|
| Concentration (mg/L) | Average Diameters of Lesions (cm) | Inhibitory Rate (%) | Mean Diameter of Spot (cm) | Inhibitory Rate (%) | |
| CX | 4000 | 0.83 | 48.04 b | 0.93 | 41.67 b |
| 2000 | 1.03 | 39.22 c | 1.18 | 26.04 c | |
| 1000 | 1.28 | 24.51 d | 1.47 | 8.33 d | |
| Tebuconazole | 86 | 0.52 | 69.61 a | 0.54 | 66.15 a |
| CK | - | 1.70 | - | 1.60 | - |
CK is negative control. Statistical significance was determined using one-way ANOVA. Different lowercase letters in the footnote in the same column show significant difference in the inhibitory rate (p < 0.05).
Spore germination inhibition rate of 7 fractions of CX extract obtained by silica gel column chromatography and 5 fractions obtained by HPLC on Botrytis cinerea.
| Samples | Concentration (mg/L) | Spore Germination Inhibition Rate (%) | |
|---|---|---|---|
| silica gel column chromatography | FrD1 | 400 | 72.35 |
| FrD2 | 0.00 | ||
| FrD3 | 74.69 | ||
| FrD4 | 22.82 | ||
| FrD5 | 0.00 | ||
| FrD6 | 74.04 | ||
| FrD7 | 21.56 | ||
| HPLC | CQ1 | 62.25 | 92.85 |
| CQ2 | 0.00 | ||
| CQ3 | 93.64 | ||
| CQ4 | 0.00 | ||
| CQ5 | 95.86 | ||
1H and 13C NMR data of CQ2 and CQ4 (CDCl3, δ in ppm, J in Hz).
| No. | CQ2 a | CQ4 a | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1 | 171.4 | 167.8 | ||
| 2 | / | |||
| 3 | 4.91 (dd, 3.7, 7.6) | 82.6 | 148.7 | |
| 3a | 161.6 | 124.1 | ||
| 4 | 2.44 (m) | 20.9 | 2.57 (t, 9.4) | 18.6 |
| 5 | 2.44 (m) | 22.5 | 2.43 (m) | 18.6 |
| 6 | 5.89 (dt, 3.4, 8.9) | 128.5 | 5.97 (m) | 130.0 |
| 7 | 6.20 (dt, 2.0, 9.7) | 116.9 | 6.24 (d, 9.5) | 117.2 |
| 7a | 124.6 | 147.2 | ||
| 8 | 1.86 (m); 1.51 (m) | 32.0 | 5.20 (t, 8.0) | 113.1 |
| 9 | 1.35 (m) | 26.8 | 2.34 (q, 7.6) | 28.2 |
| 10 | 1.35 (m) | 22.4 | 1.47 (m) | 22.5 |
| 11 | 0.89 (t, 7.1) | 14.0 | 0.93 (t, 7.4) | 13.9 |
a: Recorded at 400 MHz for 1H and 100 MHz for 13C. dd: doublet of doublets, m: multiplet, dt: double triple peak, t: triple peak, d: double peak, q: quadruple peak
Determination results of the MIC of compounds CQ2 and CQ4 against the four pathogenic fungi.
| Treatments | MIC (mg/L) | |||
|---|---|---|---|---|
|
|
|
|
| |
| Senkyunolide A | 7.81 | 250 | 250 | 250 |
| Ligustilide | 62.25 | 125 | 500 | 250 |
| pyraclostrobine | 40 | 2 | 1.25 | 2.5 |
Figure 1Structural formula of Senkyunolide A.
Figure 2Structural formula of Ligustilide.